FARMACOS OTOTOXICOS PDF

Farmacos ototoxicos. Uploaded by. Graciela Alejandra Lanchipa Gamarra. Analisis de Heces Caseros. Uploaded by. Graciela Alejandra Lanchipa Gamarra. Provincia de Yunguyo. Adecuada Alimentación del Estudiante universitario. Farmacos ototoxicos. Semiología de Los Signos Vitales. Analisis de Heces Caseros. CONCLUSIÓN Actividades preventivas y reforzamiento de conductas saludables . Políticas públicas para la prevención de anomalías.

Author: Akinokazahn Kigazil
Country: Barbados
Language: English (Spanish)
Genre: Photos
Published (Last): 8 June 2015
Pages: 43
PDF File Size: 8.58 Mb
ePub File Size: 6.36 Mb
ISBN: 398-9-90383-838-6
Downloads: 4267
Price: Free* [*Free Regsitration Required]
Uploader: Dugar

“).f(b.get([“domainName”],!1),b,”h”).w(“

Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. Drug Saf ;13 4: Services on Demand Journal. Early detection of cisplatin-induced ototoxicity using evoked otoacoustic emissions. Comparison of distortion product OAE generation between a patient growth requirent frequent gentamicin therapy and control subjects.

The importance of high-tone audiometry in monitoring for ototoxicity.

Barros A et al. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Esto se debe a la falta de profundidad de la anamnesis -en ocasiones- y en otras, al desconocimiento de los familiares.

Rev Ototkxicos Otorrinolaringol ;67 6: Comparative adverse effect profiles of platinum drugs. Ototoxicidade induzida por cis-diamminedichloroplatinum NSC – We have carried on a study during a six months period in the Pereira Rossell Hospital detecting evoked otoacoustic emissions in newborns. Evoked otoacoustic emissions–an approach for monitoring cisplatin induced ototoxicity in children.

  JURNAL KEJU MOZZARELLA PDF

Segundo Kemp 35 e Probst et al. Arch Pediatr Uruguay ; 42 4: Ear Hear ; Rev Bras Otorrinolaringol ;66 6: Changes in transitory evoked otoacoustic emissions in farnacos with cisplatin and 5FU.

Absence of otoacoustic emissions in subjects with normal audiometric thresholds implies exposure to noise. Auris Nasus Larynx ; Hypoacusia is an important problem in children due to its consequences on the social and intellectual future if it is not early diagnosed and treated in childhood.

Rev Bras Otorrinolaringol afrmacos 1: J Am Acad Audiol ;3 6: Se realizaron en un sector del servicio con el menor ruido ambiental posible.

farmacos ototoxicos pdf to jpg

Levinsky L, Gimaraes U. Lilian Jacob Rua Prof.

High-frequency testing techniques and instrumentation for early detection of ototoxicity. Evidence of mechanical nonlinearity and frequency selective wave amplification in the coclear.

Auditory monitoring in ototoxicity

An Esp Pediatr ; Acta Otorrinolaringol Esp ;1 5: Orotoxicos J Audiol ;32 5: J Occup Environ Med ;45 7: Use of Transient evoked otoacoustic emissions to detect and monitor cochlear damage caused by platinum- containing drugs. Audiometric test criteria in the detection of cisplatin ototoxicity.

  EOBI ACT 1976 PDF

Rev Bras Otorrinolaringol ;69 5: Por este motivo, la tendencia actual se orienta a efectuar screening auditivo universal en los primeros 3 meses de vida.

Spontaneous, click a tone burst-evoked emissions from normal ears. El objetivo del trabajo es: Mulheran M, Degg C. Monitoring and predicting ototoxic damage using distortion-product otoacustic emissions: A literatura apontou dois principais procedimentos efetivos no farmzcos En cambio, del grupo con peso mayor de 1.

An Individualized, sensitive frequency range for early detection of ototoxicity. Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatinum therapy. Hear Res ;21 3: Lazlo K, Stein PhD. Otoacoustic emissions for monitoring aminoglycoside-induced ototoxicity in children with cystic fibrosis. Br J Audiol ;31 1: El extremo de la sonda va acoplado a un terminal de goma ajustable a las distintas medidas del conducto auditivo externo.

Rev Bras Otorrinolaringol ;67 3: Mc Graw-Hill Interamericana, Rev Bras Otorrinolaringol ;69 2: